Scholarlink

<p>This paper introduce new rout preparation of Zinc oxide nanoparticles (ZnO NPs) via green laser ablation. V<sub>2</sub>O<sub>5</sub>@ZnO was synthesized via co-precipitation. The fabricated ZnO and V<sub>2</sub>O<sub>5</sub>@ZnO have been annealed at 900&#xa0;°C. In vitro antibacterial experiments have been conducted for the prepared samples against negative and positive organisms. Additionally, this study discusses the impact of vanadium oxide insertion on the cytotoxicity of zinc oxide toward the human osteoblast cell line.&#xa0;The value of cell viability for ZnO was around 78.72 ± 3.54 and improved to 89.64 ± 2.65% for V<sub>2</sub>O<sub>5</sub>@ZnO nanocomposite approve the good biocompatibility of samples. The antibacterial activity of V<sub>2</sub>O<sub>5</sub>@ZnO nanocomposite that has been fabricated via co-precipitation method and annealed at 900&#xa0;°C has been enhanced. The inhibation zone against <i>B. subtilis</i>, <i>S. aureus</i>, <i>P. aeruginosa</i>, and <i>E. coli</i> have been modified to 17.57 ± 0.67, 10.94 ± 0.35, 18.26 ± 0.91, 17.72 ± 0.98, respectively suggesting the application of the fabricated V<sub>2</sub>O<sub>5</sub>@ZnO in biological use such as wound healing.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Synthesis of vanadium pentoxide doped zinc oxide nanocomposites via laser ablation and their antibacterial activity and cell viability

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月4日

查看全文
  • A. A. Menazea

摘要

This paper introduce new rout preparation of Zinc oxide nanoparticles (ZnO NPs) via green laser ablation. V2O5@ZnO was synthesized via co-precipitation. The fabricated ZnO and V2O5@ZnO have been annealed at 900 °C. In vitro antibacterial experiments have been conducted for the prepared samples against negative and positive organisms. Additionally, this study discusses the impact of vanadium oxide insertion on the cytotoxicity of zinc oxide toward the human osteoblast cell line. The value of cell viability for ZnO was around 78.72 ± 3.54 and improved to 89.64 ± 2.65% for V2O5@ZnO nanocomposite approve the good biocompatibility of samples. The antibacterial activity of V2O5@ZnO nanocomposite that has been fabricated via co-precipitation method and annealed at 900 °C has been enhanced. The inhibation zone against B. subtilis, S. aureus, P. aeruginosa, and E. coli have been modified to 17.57 ± 0.67, 10.94 ± 0.35, 18.26 ± 0.91, 17.72 ± 0.98, respectively suggesting the application of the fabricated V2O5@ZnO in biological use such as wound healing.